🇺🇸 FDA
Patent

US 9943524

Use of alkaloid in preparing pharmaceutical compositions for preventing or treating pulmonary fibrosis

granted A61KA61K31/55A61K31/553

Quick answer

US patent 9943524 (Use of alkaloid in preparing pharmaceutical compositions for preventing or treating pulmonary fibrosis) held by CHINA PHARMACEUTICAL UNIVERSITY expires Mon Apr 12 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
CHINA PHARMACEUTICAL UNIVERSITY
Grant date
Tue Apr 17 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Apr 12 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
6
CPC classes
A61K, A61K31/55, A61K31/553, A61P, A61P11/00